Vineet Laboratories Limited specializes in the manufacture of drug intermediates and bulk drugs, vital components for active pharmaceutical ingredients (APIs).

Its state-of-the-art facility boasts a versatile setup with stainless steel and glass-lined reactors, suited for varying batch sizes and specialized in handling pyrophoric chemicals like n-Butyl Lithium.

The company focuses on exporting API intermediates, fine chemicals, and custom synthesis molecules, collaborating with exporters globally.

Originally Ortin Laboratories, the company underwent a demerger in 2020, strengthening its focus on pharmaceutical intermediates and fine chemicals.

Vineet Laboratories is a preferred partner for renowned companies such as Gilead Sciences and Cipla, highlighting its strong capabilities in product development and process technology.